SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

In view of the continuing COVID-19 pandemic, the Ministry of Corporate Affairs (‘MCA’) has, through its Circular No. 20/2020 dated 5th May, 2020, read with Circular No. 14/2020 dated 8th April, 2020, Circular No.17/2020 dated 13th April, 2020 and Circular No.02/2021 dated 13th January, 2021 (collectively referred to as ‘MCA Circulars’), permitted the holding of the Annual General Meeting (‘AGM’) through Video Conferencing (‘VC’)/ Other Audio -Visual Means (‘OAVM’), without the physical presence of the Members at a common venue. Further to intimation dated 30th April, 2021, Astec LifeSciences has informed that in compliance with the provisions of the Companies Act, 2013 (‘the Act’), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) and MCA Circulars, the Company has decided to hold its 27th AGM on Wednesday, 28th July, 2021 at 4.00 pm (IST) through VC/ OAVM. Pursuant to General Circular No. 20/2020 dated 5th May, 2020 issued by MCA, read with Regulations 47, 30 and Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has attached the copies of newspaper advertisements published on Friday, 2nd July, 2021 in ‘Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language)’ in respect of information regarding the 27th AGM of the Company. The newspaper advertisements may also be accessed on the website of the Company: www.astecls.com.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

703.00 -23.50 (-3.23%)
20-Apr-2026 15:25 View Price Chart
Peers
Company Name CMP
UPL 655.70
PI Industries 3022.60
Bayer CropScience 4847.70
Sharda Cropchem 1101.95
Sumitomo Chemical 445.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×